Accelera Innovations, Inc (ACNV) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAccelera Innovations, Inc (ACNV) trades at $0.0001. Accelera Innovations, Inc. is a U.S.-based healthcare service company specializing in the development of Internet-based software. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for ACNV: ACNV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Accelera Innovations, Inc (ACNV) Healthcare & Pipeline Overview
Accelera Innovations, Inc. is a U.S. healthcare service provider developing internet-based software, Accelera Technology, to enhance clinical data accessibility for consumers. It also offers comprehensive billing, practice management, and administrative services to clinicians, complemented by home health services in the Chicago area, positioning itself within the evolving digital healthcare landscape.
What Is the Investment Thesis for ACNV?
Accelera Innovations, Inc. (ACNV) operates in the U.S. healthcare services sector, leveraging its Internet-based Accelera Technology platform to enhance clinical data accessibility for consumers and provide critical administrative support to clinicians. The company's value proposition is centered on improving healthcare service functionality through digital solutions, alongside offering billing, practice management, and home health services in specific markets like Chicago. ACNV's reported 100.0% Gross Margin suggests efficient direct cost management for its services, although this is contrasted by a significant Profit Margin of -70010.7%, indicating substantial operational expenses or early-stage revenue generation relative to costs. The company's market capitalization of $0.00B reflects its current valuation as an OTC-traded entity. Its negative Beta of -1.62 suggests an inverse relationship with overall market movements, which could be a point of interest for diversification strategies, though such a high negative beta is uncommon and warrants careful examination. Future growth could be driven by increased adoption of its Accelera Technology platform, expansion of its administrative services to a broader clinician base, or geographic expansion of its home health services beyond Chicago. However, the company's substantial negative profit margin and OTC "Other" tier status present ongoing operational and disclosure risks that require thorough due diligence.
Based on FMP financials and quantitative analysis
ACNV Key Highlights
Market Capitalization: Accelera Innovations, Inc. has a reported market capitalization of $0.00B, reflecting its current valuation within the OTC market.
- Gross Margin: The company exhibits a 100.0% Gross Margin, indicating that the direct costs associated with its services are either negligible or fully covered by its revenue streams.
- Profit Margin: A significant Profit Margin of -70010.7% points to substantial operational expenses or insufficient revenue generation to cover its overall cost structure.
- Beta: Accelera Innovations, Inc. has a Beta of -1.62, suggesting an inverse relationship with broader market movements, which is an uncommon characteristic for a healthcare service company.
- Core Business: The company's primary operational focus is on developing Internet-based software for clinical healthcare data accessibility and providing billing, practice management, and home health services.
Who Are ACNV's Competitors?
ACNV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $0.16 | -10.33% | $6.45M | — |
| ACON Aclarion, Inc. | $2.38 | -2.46% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.44 | -9.03% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | -1.72% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.43 | +3.72% | $24.1M | — |
| ONMD OneMedNet Corporation | $5.39 | -2.00% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.24 | +8.33% | $32.2M | — |
| CCLD CareCloud, Inc. | $2.02 | -0.98% | $85.8M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ACNV's Key Strengths?
Proprietary Internet-based software platform (Accelera Technology) for healthcare data.
- Diversified service offerings including software, administrative support, and direct patient care.
- Established operational history in the healthcare sector since its founding in 2008.
- Reported 100.0% Gross Margin, indicating efficient direct cost management for services.
What Are ACNV's Weaknesses?
Significant negative Profit Margin of -70010.7%, highlighting substantial operational losses.
- Limited geographic scope for home health services, currently focused only on Chicago.
- OTC "Other" tier classification, implying limited disclosure and potentially low liquidity.
- Market capitalization of $0.00B, suggesting a very small scale or limited public trading activity.
What Are the Key Risks for ACNV?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Significant operational losses as evidenced by a -70010.7% Profit Margin, impacting financial stability.
- Challenges associated with its "OTC Other" tier status, including limited disclosure and liquidity.
- Intense competition from more established and better-funded healthcare IT and service providers.
- Regulatory changes in healthcare, particularly concerning data privacy and service delivery, impacting operations.
- Difficulty in securing additional capital for growth and operations given its current financial profile and market status.
What Are ACNV's Competitive Advantages?
- Proprietary Accelera Technology platform for clinical data accessibility.
- Integrated service offering combining software with administrative and direct patient care.
- Established operational presence in healthcare services since 2008.
- Targeted geographic focus for home health services (Chicago), potentially allowing for localized market penetration.
What Does ACNV Do?
Accelera Innovations, Inc., founded in 2008 and headquartered in Colorado Springs, Colorado, operates as a healthcare service company primarily within the United States. The company's core strategic focus revolves around the development and deployment of Internet-based software solutions designed to optimize various facets of healthcare service delivery. Initially established as Accelerated Acquisitions IV, Inc., the company underwent a significant rebranding in October 2011, adopting its current name, Accelera Innovations, Inc., to better reflect its evolving mission and technological emphasis. At the heart of Accelera Innovations' offering is its proprietary Accelera Technology. This Internet-based software platform is engineered to significantly enhance both the functionality and overall performance of healthcare services. A key capability of this platform is its ability to facilitate the secure and efficient availability of clinical healthcare data directly to healthcare consumers. This focus on data accessibility aims to empower patients with more direct insight into their health information, potentially leading to improved engagement and informed decision-making regarding their care. Beyond its core software platform, Accelera Innovations, Inc. diversifies its service portfolio to address critical operational needs within the healthcare ecosystem. The company provides comprehensive billing services, which are essential for revenue cycle management and financial stability for healthcare providers. Complementing this, it offers practice management services, assisting doctors and other clinicians in streamlining their daily operations, appointment scheduling, patient records management, and overall administrative efficiency. These administrative services are designed to alleviate the non-clinical burdens on healthcare professionals, allowing them to dedicate more time to patient care. Furthermore, Accelera Innovations extends its reach into direct patient care through the provision of home health services. These services are specifically offered to patients located in the Chicago area, indicating a targeted geographic expansion for certain service lines. This blend of technology development, administrative support, and direct patient care positions Accelera Innovations as a multifaceted entity aiming to address various pain points within the U.S. healthcare landscape, from data management to operational efficiency and direct patient support. The company's evolution since its founding reflects a commitment to leveraging technology to improve healthcare accessibility and operational effectiveness.
What Products and Services Does ACNV Offer?
- Develops Internet-based software for the healthcare sector in the United States.
- Offers Accelera Technology, a software platform enhancing healthcare service functionality.
- Makes clinical healthcare data available to healthcare consumers through its platform.
- Provides billing services to doctors and other clinicians.
- Offers practice management services to healthcare professionals.
- Delivers administrative services to support doctors and clinicians.
- Provides home health services to patients in the Chicago area.
How Does ACNV Make Money?
- Software licensing or subscription fees for its Accelera Technology platform.
- Fees for billing services provided to doctors and clinicians.
- Fees for practice management and administrative services offered to healthcare professionals.
- Revenue generated from providing home health services to patients in Chicago.
What Industry Does ACNV Operate In?
Accelera Innovations, Inc. operates within the Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector characterized by increasing demand for digital solutions to manage patient data, streamline operations, and enhance service delivery. The industry is driven by trends such as the digitization of health records, the push for interoperability, and the growing emphasis on patient engagement through accessible data. Accelera's Accelera Technology platform, which focuses on making clinical healthcare data available to consumers, directly addresses these trends by aiming to improve data accessibility and functionality. While the company also provides traditional billing, practice management, and administrative services, its software development focus positions it alongside firms leveraging technology for healthcare efficiency. The competitive landscape includes established enterprise software providers, specialized health IT firms, and other service providers, all vying for market share in an evolving regulatory and technological environment. Accelera's niche in both software and direct service provision, particularly home health in Chicago, offers a diversified approach within this dynamic industry.
Who Are ACNV's Key Customers?
- Doctors and other clinicians seeking administrative and operational support.
- Healthcare consumers interested in accessing their clinical data.
- Healthcare practices and organizations requiring billing and practice management solutions.
- Patients in the Chicago area needing home health services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Accelera Innovations, Inc operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Colorado Springs, US. The company is led by CEO Geoffrey J. Thompson. ACNV has traded publicly since 2015.
Key Financial Metrics
Return on equity for Accelera Innovations, Inc stands at 84.7%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Accelera Innovations, Inc's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ACNV Financials
ACNV Latest News
No recent news available for ACNV.
ACNV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ACNV.
Price Targets
Wall Street price target analysis for ACNV.
ACNV MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ACNV; grades run from A+ (80-100) to F (below 30).
ACNV OTC Market Information
The "OTC Other" tier (formerly known as the Pink Sheets or Pink Current) is the lowest and most speculative tier of the OTC market. Companies in this tier are not required to meet any minimum financial standards, nor are they obligated to provide regular financial disclosures to OTC Markets Group. Unlike companies on OTCQX or OTCQB, which have specific reporting requirements, "OTC Other" companies may or may not provide public information. This tier is characterized by its highly speculative nature and significantly higher risk due to the potential lack of current information, making it challenging for investors to conduct thorough due diligence.
- OTC Tier: OTC Other
- Lack of public financial information due to "Unknown" disclosure status, hindering investor analysis.
- Extremely low liquidity and wide bid-ask spreads, making efficient trading difficult.
- High potential for price manipulation and fraud due due to minimal regulatory oversight in this tier.
- Difficulty in accurately valuing the company without reliable and consistently available financial data.
- Limited access to capital markets, potentially hindering growth and operational stability.
- Verify any available financial statements directly from the company or third-party filings, if they exist.
- Research any news or press releases issued by the company, scrutinizing for consistency and credibility.
- Examine the company's website and corporate communications for signs of active business operations.
- Investigate any regulatory actions or alerts from FINRA or the SEC related to the company or its management.
- Assess the current trading activity, including volume and bid-ask spread, to gauge actual market interest.
- Confirm the company's physical address and contact information, and attempt direct communication if possible.
- Evaluate management's background and any past business ventures for red flags, if information becomes available.
- Presence of an active company website with updated information about its products and services.
- Issuance of legitimate press releases detailing business developments, if any are found outside the provided data.
- Clear identification of management and board members, should more information become publicly available.
- Evidence of actual business operations, such as customer testimonials or product usage, if verifiable.
- Any voluntary disclosures or filings made with OTC Markets Group, even if not mandatory for this tier.
Common Questions About ACNV (Healthcare)
What does Accelera Innovations, Inc do?
Accelera Innovations, Inc. is a U.S.-based healthcare service company focused on developing Internet-based software and providing essential administrative and direct patient care services. This aims to empower patients with better access to their health information.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Analysis relies solely on the provided source data, which is limited, particularly for detailed financial metrics beyond basic margins and market cap, and for competitive landscape information.
- The company's OTC "Other" tier classification inherently implies higher risks due to potential lack of consistent public disclosure and low liquidity.
- Specific background and track record for the CEO, Geoffrey J.